Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Basit Öğe Kaydı
dc.authoridDadduzio, Vincenzo/0000-0002-3193-6632
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidDadduzio, Vincenzo/AAA-6562-2019
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorBlanc, J. F.
dc.contributor.authorMeyer, T.
dc.contributor.authorCheng, A-L.
dc.contributor.authorEl-Khoueiry, A. B.
dc.contributor.authorCicin, I.
dc.contributor.authorChen, Y.
dc.contributor.authorBolondi, L.
dc.date.accessioned2024-06-12T11:24:01Z
dc.date.available2024-06-12T11:24:01Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncolen_US
dc.description.sponsorshipExelixis, Inc.en_US
dc.description.sponsorshipExelixis, Inc.en_US
dc.identifier.endpage237en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpage237en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26779
dc.identifier.volume29en_US
dc.identifier.wosWOS:000459277301282en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleAssessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu